Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

This study has been completed.
Information provided by (Responsible Party):
University of Pittsburgh Identifier:
First received: August 10, 2006
Last updated: December 16, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)